mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |